Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 3, 2007, Pages 257-261

  Calzavara, Liviana ^a,d   Ramuscak, Nancy ^a   Burchell, Ann N ^e   Swantee, Carol ^b   Myers, Ted ^a   Ford, Peter ^c   Fearon, Margaret ^b   Raymond, Sue ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY SCREENING; ARTICLE; CANADA; CONFIDENCE INTERVAL; DEMOGRAPHY; FEMALE; GROUPS BY AGE; HEALTH CARE FACILITY; HEALTH SURVEY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFORMATION PROCESSING; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OFFENDER; POPULATION RESEARCH; PREVALENCE; SALIVA ANALYSIS; CLASSIFICATION; COMORBIDITY; CROSS-SECTIONAL STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PRISON; SALIVA; SEXUAL BEHAVIOR; STATISTICS; SUBSTANCE ABUSE; VIROLOGY;

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; ONTARIO; PREVALENCE; PRISONS; SALIVA; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34547563842     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.060416     Document Type: Article

References (20)

1. Hepatitis C information for health professionals. Ottawa: Health Canada; 2002. Cat no H39-601/2002E. Available: www.phac-aspc.gc.ca/hepc/pubs/ pdf/hepcinfo -healthprof_e.pdf (accessed 2007 June 1).
2. HIV/AIDS EPI updates. Ottawa: Health Canada; 2004. Cat no H39-1/1-2004E-PDF. Available: www.phac-aspc.gc.ca/publicat/epiu-aepi/ epi_update_may_04/pdf/epi _may_2004_e.pdf (accessed 2007 June 1).
3. Ford PM, Pearson M, Sankar-Mistry P, et al. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group. QJM 2000;93:113-9.
4. De P, Connor N, Bouchard F, et al. HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: a critical opportunity for care and prevention. Can J Infect Dis Med Microbiol 2004;15:221-5.
5. Ford PM. Voluntary Screening for hepatitis C in a Canadian federal penitentiary for men. Can Commun Dis Rep 1995;21:134-6.
6. Prefontaine R, Chauhary R, Mathias R. Analysis of risk factors associated with hepatitis B and C infection in correctional institutions in British Columbia. Can J Infect Dis 1994;5:153-6.
7. Smith J. Viral hepatitis in Canadian federal penitentiaries. Focus Infect Dis 2005; 3(1):1-2. Available: www.csc-scc.gc.ca/text/pblct/ hsbulletin/2005/n01/2_e.shtml (accessed 2007 June 1).
8. Dufour A, Alary M, Poulin C, et al. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996;10:1009-15.
9. Rothon D, Mathias R, Schecter M. Prevalence of HIV infection in provincial prisons in British Columbia. CMAJ 1994;151:781-7.
10. Calzavara L, Burchell A, Schlossberg J, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction 2003;98:1257-65.
11. Annual correctional statistics - 2003/04. Toronto: Program Effectiveness, Statistics and Applied Research Unit, Correctional Services Division, Ontario Ministry of Community Safety and Correctional Services.
12. Calzavara L, Major C, Myers T, et al. Reducing volunteer bias: using left-over specimens to estimate rates of HIV infection among inmates in Ontario, Canada. AIDS 1995;9:631-7.
13. Calzavara L, Major C, Myers T, et al. The prevalence of HIV-1 infection among inmates in Ontario, Canada. Can J Public Health 1995;86:335-9.
14. Van Doornum GJJ, Lodder A, Buimer M, et al. Evaluation of hepatitis C antibody testing in saliva specimens collected by two different systems in comparison with HCV antibody and HCV RNA in serum. J Med Virol 2001;64:13-20.
15. Greenland S. Basic methods for sensitivity analysis and external adjustment. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998. p. 343-57.
16. Hankins C, Gendron S, Handley M, et al. HIV infection among women in prison: an assessment of risk factors using a non-nominal methodology. Am J Public Health 1994;84:1637-40.
17. Hankins C, Gendron S, Richard C, et al. HIV-1 infection in a medium security prison for women - Quebec. Can Dis Wkly Rep 1989;15:168-70.
18. Pongrac MB. HIV, hepatitis C virus (HCV) in women offenders - Why are the rates so high? Focus Infect Dis 2002;1(2):5-6. Available: www.csc-scc.gc.ca/text/pblct/hsbulletin/2002/n02/4_e.shtml (accessed 2007 June 1).
19. Gates J, Post J, Kaldor J, et al. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia. J Urban Health 2004;81:448-52.
20. Remis RS, Swantee C, Rottensten K, et al. Report on HIV/AIDS in Ontario 2003. Toronto: Ontario Ministry of Health and Long-Term Care; 2004. Available: www.phs.utoronto.ca/ohemu/doc/PHERO03R.pdf (accessed 2007 June 25].